These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors. Kita J, Tamai M, Arima K, Nakashima Y, Suzuki T, Kawashiri SY, Okada A, Koga T, Yamasaki S, Nakamura H, Origuchi T, Aramaki T, Nakashima M, Fujikawa K, Tsukada T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Mod Rheumatol; 2012 Apr; 22(2):195-201. PubMed ID: 21898075 [Abstract] [Full Text] [Related]
7. Predictive value of ultrasonographic assessment of disease activity in response to tumor necrosis factor-α inhibitor treatment in rheumatoid arthritis: a prospective cohort study. Inanc N, Ozen G, Direskeneli H. Clin Exp Rheumatol; 2016 Apr; 34(1):156. PubMed ID: 26575409 [No Abstract] [Full Text] [Related]
8. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study. Saleem B, Brown AK, Keen H, Nizam S, Freeston J, Karim Z, Quinn M, Wakefield R, Hensor E, Conaghan PG, Emery P. Arthritis Rheum; 2009 Jul; 60(7):1915-22. PubMed ID: 19565512 [Abstract] [Full Text] [Related]
9. Tight control is important in patients with rheumatoid arthritis treated with an anti-tumor necrosis factor biological agent: prospective study of 91 cases who used a biological agent for more than 1 year. Sano H, Arai K, Murai T, Fujisawa J, Kondo N, Netsu T, Hanyu T, Saeki T, Ito T, Endo N. Mod Rheumatol; 2009 Jul; 19(4):390-4. PubMed ID: 19466615 [Abstract] [Full Text] [Related]
11. Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. Genovese MC, Fleischmann RM, Greenwald M, Satterwhite J, Veenhuizen M, Xie L, Berclaz PY, Myers S, Benichou O. Ann Rheum Dis; 2013 Sep 01; 72(9):1461-8. PubMed ID: 23268367 [Abstract] [Full Text] [Related]
16. Treatment of rheumatoid arthritis: we are getting there. Yazici Y. Lancet; 2009 Jul 18; 374(9685):178-80. PubMed ID: 19560809 [No Abstract] [Full Text] [Related]
17. Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis. Kamishima T, Kato M, Atsumi T, Koike T, Onodera Y, Terae S. Clin Exp Rheumatol; 2013 Jul 18; 31(1):154. PubMed ID: 23190694 [No Abstract] [Full Text] [Related]
18. Anti-TNF scintigraphy to assess TNF-α-associated joint inflammation in rheumatoid arthritis and osteoarthritis. Hermann J, Lipp RW, Dunzinger A, Spreizer C, Schaffler G, Kvaternik H, Ofner P, Graninger W. Clin Exp Rheumatol; 2014 Jul 18; 32(4):614. PubMed ID: 24959905 [No Abstract] [Full Text] [Related]